Photo by Eisfelder via Wikimedia Commons New research has documented a significant impact of severe atopic dermatitis (AD) on a child’s height, and that dupilumab treatment can help improve growth. The study, published in the Journal of the American Academy of Dermatology, investigated the effect of a medication commonly used to treat AD on growth and bone biomarkers in 123 children aged six to 11 years with severe eczema. Researchers found that children who had severe AD and

New research suggests a “tailored vaccine” might hold the key to treating bacteria-driven atopic dermatitis (AD) flares in children....

Recently published findings from clinical trials of the oral Janus kinase (JAK) inhibitor upadacitinib show it is highly effective in...